Piotr Bobrowicz

Piotr Bobrowicz has a strong background in the biotechnology industry, with experience at various companies and organizations. Piotr currently serves as the President of Alloy Therapeutics, Inc. since June 2023, where they are responsible for leading the company's efforts in empowering the global scientific community to develop better medicines. Prior to this role, they held the position of President and Chief Scientific Officer at Alloy Therapeutics, Inc. from 2020 to June 2023, contributing to the company's growth and collaboration with over 100 partners. Piotr also served as the Chief Scientific Officer at Compass Therapeutics Inc. from 2014 to 2019, playing a key role in the development of antibody-based therapeutics for oncology. Before that, they worked at Adimab as the Director of Technology and Platform Development, leading successful antibody discovery projects in partnership with big pharma and biotech companies. Piotr started their career as a Senior Scientist at GlycoFi and later became a Group Leader at Merck. Piotr began their professional journey as a Postdoctoral Researcher at Texas A&M University, where they honed their research skills.

Piotr Bobrowicz earned their Master of Science in Microbiology from the University of Wroclaw in 1994. Piotr then pursued a Doctor of Philosophy degree in Biology at the same university from 1994 to 1997. Additionally, they participated in the TEMPUS program at the University of Rome Tor Vergata in 1993.